The use of functional epirubicin liposomes to induce programmed death in refractory breast cancer
Lei Liu, Li-Min Mu, Yan Yan, Jia-Shuan Wu, Ying-Jie Hu, Ying-Zi Bu, Jing-Ying Zhang, Rui Liu, Xue-Qi Li, Wan-Liang Lu Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Be...
Guardado en:
Autores principales: | Liu L, Mu LM, Yan Y, Wu JS, Hu YJ, Bu YZ, Zhang JY, Liu R, Li XQ, Lu WL |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6ffa3316fd20403a95fbf0055f3ed66b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nicotine exacerbates tacrolimus-induced renal injury by programmed cell death
por: Yu Ji Jiang, et al.
Publicado: (2021) -
Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain glioma
por: Ju RJ, et al.
Publicado: (2016) -
Tocilizumab in refractory rheumatoid arthritis: long-term efficacy, safety, and tolerability beyond 2 years
por: Farah Z, et al.
Publicado: (2016) -
Augmentation uretero-enterocystoplasty for refractory urinary tract dysfunction: a long-term retrospective study
por: Xiaoqian Ying, et al.
Publicado: (2021) - Refractories and industrial ceramics